Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVA Inventiva S.A.

交易中 08-18 15:26:17 EDT

4.65

-0.05

-1.17%

最高4.66	最低4.45	成交量68.20万
今开4.64	昨收4.70	日振幅4.47%
总市值10.96亿	流通市值8.41亿	总股本2.36亿
成交额309.08万	换手率0.38%	流通股本1.81亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":4.645,"timestamp":1787081144335,"preClose":4.7,"halted":0,"volume":682040,"delay":0,"changeRate":-0.011702127659574596,"floatShares":181000000,"shares":236000000,"eps":-2.230832,"marketStatus":"交易中","change":-0.055,"latestTime":"08-18 15:26:17 EDT","open":4.64,"high":4.66,"low":4.45,"amount":3090825.90348,"amplitude":0.044681,"askPrice":4.67,"askSize":950,"bidPrice":4.64,"bidSize":456,"shortable":3,"etf":0,"ttmEps":-2.230832,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787083200000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":4.7,"preHourTrading":{"tag":"盘前","latestPrice":4.64,"preClose":4.7,"latestTime":"09:25 EDT","volume":1255,"amount":5861.6023725,"timestamp":1787059513255,"change":-0.06,"changeRate":-0.012766,"amplitude":0.034043},"postHourTrading":{"tag":"盘后","latestPrice":4.7,"preClose":4.7,"latestTime":"17:57 EDT","volume":1134,"amount":5329.77,"timestamp":1787003832391,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.52606,"impliedVol":3.3745,"impliedVolPercentile":0.8161},"requestUrl":"/m/hq/s/IVA/tweets","defaultTab":"tweets","newsList":[{"id":"1198128133","title":"财报前瞻｜Inventiva S.A.本季度营收预计下降100.00%，机构观点看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1198128133","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198128133?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:52","pubTimestamp":1774234325,"startTime":"0","endTime":"0","summary":"Inventiva S.A.计划于2026年03月30日披露财报，本篇聚焦市场一致预期与公司最新季度关键财务指标，并结合近期机构观点给出结构化研判。市场一致预期显示，本季度Inventiva S.A.营收预计为0.00欧元，同比下降100.00%；调整后每股收益预计为-0.24，同比改善48.37%；息税前利润预计为-2,562.75万欧元，同比下降4.88%。上一季度，Inventiva S.A.营收为4.60万欧元；毛利率为100.96%；归属于母公司股东的净利润为-8,794.10万欧元；净利率数据未披露；调整后每股收益为0.00。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Inventiva S.A.本季度营收预计下降100.00%，机构观点看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617509673","title":"Inventiva Sa盘中异动 早盘急速拉升5.15%报6.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617509673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2617509673?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:56","pubTimestamp":1772722594,"startTime":"0","endTime":"0","summary":"北京时间2026年03月05日22时56分，Inventiva Sa股票出现异动，股价快速上涨5.15%。截至发稿，该股报6.33美元/股，成交量3.5611万股，换手率0.02%，振幅3.41%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为1.17%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305225634a4505241&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305225634a4505241&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBO","IVA","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610662075","title":"Inventiva Sa盘中异动 早盘大幅上涨5.05%报6.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610662075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2610662075?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:39","pubTimestamp":1770734369,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时39分，Inventiva Sa股票出现波动，股价大幅拉升5.05%。截至发稿，该股报6.24美元/股，成交量13.3951万股，换手率0.06%，振幅2.02%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.08%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223929a4940c3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223929a4940c3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518758972","title":"Inventiva Sa盘中异动 急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518758972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518758972?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:46","pubTimestamp":1741614375,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时46分，Inventiva Sa股票出现波动，股价大幅下跌5.14%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2547.15%、588.39%、88.73%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021461598a2a0e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021461598a2a0e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517167355","title":"Inventiva Sa盘中异动 大幅拉升5.91%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517167355?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:07","pubTimestamp":1741277227,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时07分，Inventiva Sa股票出现异动，股价急速上涨5.91%。截至发稿，该股报2.92美元/股，成交量1471股，换手率0.00%，振幅5.43%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.35%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000707989ec6ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000707989ec6ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677303","title":"Inventiva Sa盘中异动 早盘股价大跌7.09%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677303?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098745,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Inventiva Sa股票出现异动，股价大幅下跌7.09%。截至发稿，该股报2.75美元/股，成交量1.0787万股，换手率0.02%，振幅1.01%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.25%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223225abe7efc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223225abe7efc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516659446","title":"Inventiva Sa盘中异动 股价大跌5.36%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516659446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516659446?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:35","pubTimestamp":1741023323,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时35分，Inventiva Sa股票出现波动，股价快速下挫5.36%。截至发稿，该股报3.00美元/股，成交量3418股，换手率0.01%，振幅4.73%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.26%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040135239637d5f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040135239637d5f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516376064","title":"Inventiva Sa盘中异动 大幅下跌6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516376064?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:48","pubTimestamp":1740757736,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时48分，Inventiva Sa股票出现异动，股价快速下跌6.13%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1937.50%、451.01%、351.46%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、41.62%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228234857abe0fcd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228234857abe0fcd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385514","title":"Inventiva Sa盘中异动 股价大跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385514?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:40","pubTimestamp":1740667200,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时40分，Inventiva Sa股票出现异动，股价快速跳水6.34%。截至发稿，该股报2.96美元/股，成交量151股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.68%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224001a2567c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224001a2567c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514153950","title":"Inventiva Sa盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514153950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514153950?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:07","pubTimestamp":1740496061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时07分，Inventiva Sa股票出现异动，股价急速上涨5.15%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.95%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230741abdc8773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230741abdc8773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512162557","title":"Inventiva Sa盘中异动 股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512162557?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:04","pubTimestamp":1739894679,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时04分，Inventiva Sa股票出现波动，股价急速上涨5.58%。截至发稿，该股报2.65美元/股，成交量7354股，换手率0.01%，振幅4.38%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.83%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219000439a24ac161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219000439a24ac161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511579854","title":"Inventiva Sa盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511579854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511579854?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:02","pubTimestamp":1739473344,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时02分，Inventiva Sa股票出现异动，股价急速上涨5.42%。截至发稿，该股报2.53美元/股，成交量2758股，换手率0.01%，振幅5.62%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.09%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214030224abcde691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214030224abcde691&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510738033","title":"Inventiva Sa盘中异动 早盘股价大跌8.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510738033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510738033?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:34","pubTimestamp":1739284461,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时34分，Inventiva Sa股票出现波动，股价急速下跌8.93%。截至发稿，该股报2.23美元/股，成交量15股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.96%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223422961f4825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223422961f4825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510696908","title":"Inventiva Sa盘中异动 早盘快速下挫5.23%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510696908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510696908?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:23","pubTimestamp":1739200998,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时23分，Inventiva Sa股票出现异动，股价大幅跳水5.23%。截至发稿，该股报2.31美元/股，成交量226股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.16%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210232318961e0b45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210232318961e0b45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509625328","title":"Inventiva Sa盘中异动 下午盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509625328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509625328?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:01","pubTimestamp":1738785698,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时01分，Inventiva Sa股票出现波动，股价急速拉升5.02%。截至发稿，该股报2.59美元/股，成交量1840股，换手率0.00%，振幅3.45%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为2.46%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206040138a23abf3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206040138a23abf3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621581","title":"Inventiva Sa盘中异动 早盘股价大涨8.26%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507621581?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:30","pubTimestamp":1738247443,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时30分，Inventiva Sa股票出现波动，股价快速上涨8.26%。截至发稿，该股报2.49美元/股，成交量5384股，换手率0.01%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.00%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223043abbd4bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223043abbd4bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506051758","title":"Inventiva Sa盘中异动 股价大跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506051758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506051758?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:23","pubTimestamp":1738077824,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时23分，Inventiva Sa股票出现波动，股价急速下跌5.64%。截至发稿，该股报2.15美元/股，成交量1988股，换手率0.00%，振幅4.33%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.19%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128232345abbb71c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128232345abbb71c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506303871","title":"Inventiva Sa盘中异动 早盘快速上涨5.25%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506303871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506303871?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:45","pubTimestamp":1737989102,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时45分，Inventiva Sa股票出现波动，股价大幅上涨5.25%。截至发稿，该股报2.45美元/股，成交量263股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.01%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224502abba62c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224502abba62c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505669864","title":"Inventiva Sa盘中异动 早盘快速下跌5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505669864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505669864?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:16","pubTimestamp":1737731804,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时16分，Inventiva Sa股票出现波动，股价急速下挫5.95%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.52%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231644960f969e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231644960f969e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505117540","title":"Inventiva Sa股价飙升10.76% 市值涨1354.1万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505117540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505117540?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642689,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Inventiva Sa股票出现异动，股价急速拉升10.76%。截至发稿，该股报2.40美元/股，成交量8885股，换手率0.02%，振幅0.16%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.02%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223129a22d093f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223129a22d093f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inventivapharma.com","stockEarnings":[{"period":"1week","weight":-0.0105},{"period":"1month","weight":0.0173},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.2382},{"period":"1year","weight":0.078},{"period":"ytd","weight":0.0108}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0395},{"period":"3month","weight":0.0531},{"period":"6month","weight":0.1259},{"period":"1year","weight":0.2008},{"period":"ytd","weight":0.1331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inventiva S.A.成立于2011年，并于2016年注册成立。该公司是一家临床阶段的生物制药公司，专注于开发用于治疗代谢功能障碍相关脂肪性肝炎的口服小分子疗法。其主要候选药物lanifibranor是一种泛PPAR激动剂，已获得美国食品药品监督管理局的突破性疗法和快速通道资格认定，目前处于3期临床开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.098872},{"month":2,"riseRate":0.666667,"avgChangeRate":0.043927},{"month":3,"riseRate":0,"avgChangeRate":-0.112386},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.080671},{"month":5,"riseRate":0.5,"avgChangeRate":0.083353},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.137783},{"month":7,"riseRate":0.5,"avgChangeRate":-0.026084},{"month":8,"riseRate":0.428571,"avgChangeRate":0.135355},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.0365},{"month":10,"riseRate":0.666667,"avgChangeRate":0.071747},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.025201},{"month":12,"riseRate":0.833333,"avgChangeRate":0.034174}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}